Preventive vaccination against cervical cancer: Korean Society of Gynecologic Oncology Guideline / 부인종양
Journal of Gynecologic Oncology
;
: e30-2016.
Artigo
em Inglês
| WPRIM
| ID: wpr-213436
ABSTRACT
After human papillomavirus (HPV) vaccine guidelines published by Korean Society of Gynecologic Oncology (KSGO) in 2011, new studies have been published, leading to additional data regarding efficacy, safety, number of vaccination rounds, and ideal age of vaccine administration. We searched and reviewed the literatures focused on the efficacy of 2-dose schedule vaccination, the efficacy of 3-dose schedule vaccination in middle-aged women, the ideal age of 3-dose schedule vaccination, the safety of HPV preventive vaccine, and the ability of cross-protection of each HPV preventive vaccine. The KSGO has revised the previous guideline based on the results of the above studies.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Neoplasias do Colo do Útero
/
Fatores Etários
/
Resultado do Tratamento
/
Guias de Prática Clínica como Assunto
/
Vacinas contra Papillomavirus
/
República da Coreia
/
Vacina Quadrivalente Recombinante contra HPV tipos 6, 11, 16, 18
Tipo de estudo:
Guia de Prática Clínica
Limite:
Adolescente
/
Adulto
/
Criança
/
Feminino
/
Humanos
País/Região como assunto:
Ásia
Idioma:
Inglês
Revista:
Journal of Gynecologic Oncology
Ano de publicação:
2016
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS